Chelsy Marlin, DO
Family Medicine · Evansville, INNPI 1790302271
Payments from drug & device makers
Across 79 payments — averaging $17.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$385
- Vanda Pharmaceuticals Inc.$137
- Lilly USA, LLC$115
- Pfizer$85
- Novo Nordisk$74
- AstraZeneca$58
- plus $507 from 16 others
What the payments were for
- Food & beverage$1,360100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 25 | $385 |
| Vanda Pharmaceuticals Inc. | 6 | $137 |
| Lilly USA, LLC | 7 | $115 |
| Pfizer | 4 | $85 |
| Novo Nordisk | 5 | $74 |
| AstraZeneca | 3 | $58 |
| Axsome Therapeutics, Inc. | 3 | $57 |
| Bayer | 3 | $53 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $52 |
| Astellas Pharma US Inc | 2 | $45 |
| Si-bone, Inc. | 2 | $43 |
| Exact Sciences | 3 | $41 |
| Otsuka America Pharmaceutical, Inc. | 2 | $37 |
| GSK | 2 | $33 |
| Boehringer Ingelheim | 2 | $31 |
| Phathom Pharmaceuticals, Inc. | 2 | $25 |
| Teva Pharmaceuticals USA, Inc. | 1 | $18 |
| Corium, LLC | 1 | $17 |
| Merck | 1 | $15 |
| Idorsia Pharmaceuticals US Inc | 1 | $14 |
| Novartis | 1 | $14 |
| Calliditas Therapeutics US Inc. | 1 | $13 |
How this compares
$1,360 in reported general payments places this provider in the 65th percentile of 2,709 family medicine providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Albuterol Sulfate HfaAlbuterol Sulfate | 15 | $331 |
| Gabapentin | 22 | $268 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 12 | $242 |
| Atorvastatin Calcium | 34 | $140 |
| Famotidine | 19 | $135 |
| Levothyroxine Sodium | 16 | $84 |
| Tamsulosin Hcl | 11 | $84 |
| Amlodipine Besylate | 18 | $48 |
| Trazodone Hcl | 14 | $35 |
| Lisinopril | 11 | $31 |
| Alendronate Sodium | 14 | $14 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Evansville
- J Christopher SartoreEvansville$3.9M
- Hubert ReyesEvansville$3.2M
- David SchultzEvansville$3M
- Alexander Dela LlanaEvansville$1.6M
- David BrougherEvansville$556K
- Anthony InzerelloEvansville$338K
- James GutmannEvansville$311K
- Randall StoltzEvansville$248K
- William SmithEvansville$150K
- Carol GoodmanEvansville$123K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.